AcelRx Pharma (ACRX) to Announce Topline Results From Phase 3 Study of ARX-04
Tweet Send to a Friend
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) will announce the results of its multicenter, open-label Phase 3 clinical study of ARX-04, known ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
